Islets in the body are never flat: transitioning from two-dimensional (2D) monolayer culture to three-dimensional (3D) spheroid for better efficiency in the generation of functional hPSC-derived pancreatic β cells in vitro

被引:0
作者
Abdoulaye Diane
Layla Ibrahim Mohammed
Heba H. Al-Siddiqi
机构
[1] Qatar Biomedical Research Institute (QBRI),Diabetes Research Center
[2] Hamad Bin Khalifa University (HBKU),undefined
[3] Qatar Foundation (QF),undefined
来源
Cell Communication and Signaling | / 21卷
关键词
β cells; hPSC; Differentiation; Two-dimension (2D); Three-dimension (3D);
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes mellitus (DM), currently affecting more than 537 million people worldwide is a chronic disease characterized by impaired glucose metabolism resulting from a defect in insulin secretion, action, or both due to the loss or dysfunction of pancreatic β cells. Since cadaveric islet transplantation using Edmonton protocol has served as an effective intervention to restore normoglycaemia in T1D patients for months, stem cell-derived β cells have been explored for cell replacement therapy for diabetes. Thus, great effort has been concentrated by scientists on developing in vitro differentiation protocols to realize the therapeutic potential of hPSC-derived β cells. However, most of the 2D traditional monolayer culture could mainly generate insulin-producing β cells with immature phenotype. In the body, pancreatic islets are 3D cell arrangements with complex cell–cell and cell–ECM interactions. Therefore, it is important to consider the spatial organization of the cell in the culture environment. More recently, 3D cell culture platforms have emerged as powerful tools with huge translational potential, particularly for stem cell research. 3D protocols provide a better model to recapitulate not only the in vivo morphology, but also the cell connectivity, polarity, and gene expression mimicking more physiologically the in vivo cell niche. Therefore, the 3D culture constitutes a more relevant model that may help to fill the gap between in vitro and in vivo models. Interestingly, most of the 2D planar methodologies that successfully generated functional hPSC-derived β cells have switched to a 3D arrangement of cells from pancreatic progenitor stage either as suspension clusters or as aggregates, suggesting the effect of 3D on β cell functionality. In this review we highlight the role of dimensionality (2D vs 3D) on the differentiation efficiency for generation of hPSC-derived insulin-producing β cells in vitro. Consequently, how transitioning from 2D monolayer culture to 3D spheroid would provide a better model for an efficient generation of fully functional hPSC-derived β cells mimicking in vivo islet niche for diabetes therapy or drug screening.
引用
收藏
相关论文
共 336 条
[1]  
Chawla A(2016)Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20 546-551
[2]  
Chawla R(2015)Genetics of type 2 diabetes-pitfalls and possibilities Genes (Basel) 6 87-123
[3]  
Jaggi S(2015)New forms of insulin and insulin therapies for the treatment of type 2 diabetes Lancet Diabetes Endocrinol 3 638-652
[4]  
Prasad RB(2012)Insulin-pump therapy for type 1 diabetes mellitus N Engl J Med 366 1616-1624
[5]  
Groop L(2017)Sex differences in micro- and macro-vascular complications of diabetes mellitus Clin Sci (Lond) 131 833-846
[6]  
Cahn A(2017)The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study Lancet Diabetes Endocrinol 5 423-430
[7]  
Miccoli R(2021)Functional maturation of immature beta cells: a roadblock for stem cell therapy for type 1 diabetes World J Stem Cells 13 193-207
[8]  
Dardano A(2000)Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 230-238
[9]  
Del Prato S(2020)Current situation of clinical islet transplantation from allogeneic toward xenogeneic J Diabetes 12 733-741
[10]  
Pickup JC(2021)Applications of iPSC-derived beta cells from patients with diabetes Cell Rep Med 2 404-414